Stockreport

VentureMed Strengthens Commercial Leadership and Expands Clinical Evidence to Drive FLEX Vessel Prep™ System Growth [Yahoo! Finance]

Boston Scientific Corporation  (BSX) 
Last boston scientific corporation earnings: 4/29 06:30 am Check Earnings Report
US:NYSE Investor Relations: investors.bostonscientific.com
PDF arterial disease (PAD), has expanded its commercial leadership team to accelerate growth. Additionally, a new peer-reviewed publication in the Journal of Endovascular Th [Read more]